Lazard Asset Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,705
Closed -$555K 2520
2023
Q3
$555K Sell
6,705
-42
-0.6% -$3.81K ﹤0.01% 1122
2023
Q2
$642K Sell
6,747
-756
-10% -$97K ﹤0.01% 1063
2023
Q1
$1.03M Sell
7,503
-8,026
-52% -$734K ﹤0.01% 1012
2022
Q4
$1.11M Buy
15,529
+7,963
+105% +$753K ﹤0.01% 991
2022
Q3
$892K Sell
7,566
-2,582
-25% -$460K ﹤0.01% 1004
2022
Q2
$1.85M Buy
10,148
+9,920
+4,351% +$1.8M ﹤0.01% 923
2022
Q1
$53K Buy
+228
New +$46K ﹤0.01% 1715

Other funds holding DNMR

Lazard Asset Management's DNMR Position: Q4 2023 in Review

Lazard Asset Management sold out of Danimer Scientific, Inc. (DNMR) in Q4 2023, closing a stake of 6,705 shares — an estimated $555K sold.

Lazard Asset Management first reported a position in DNMR in Q1 2022 and held it in 7 quarters. The position peaked at $1.85M in Q2 2022. 140 funds tracked by Wall St. Rank hold DNMR as of Q4 2023.

  • Lazard Asset Management reported no remaining Danimer Scientific, Inc. position as of Q4 2023 after selling out during the quarter.
  • Lazard Asset Management sold 6,705 Danimer Scientific, Inc. shares in Q4 2023, an estimated $555K.
  • Lazard Asset Management first reported a position in Danimer Scientific, Inc. in Q1 2022 and held it in 7 quarters.
  • Lazard Asset Management's Danimer Scientific, Inc. position peaked at $1.85M in Q2 2022.
  • 140 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2023.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.